This prospective natural history study followed 117 untreated late-onset idiopathic scoliosis patients from the University of Iowa over 50 years. Patients were evaluated at mean age 66 and compared to 62 age-matched controls. The study answers: what actually happens to mortality, pain, pulmonary function, and daily function when late-onset idiopathic scoliosis goes untreated for five decades?
The dogma that untreated idiopathic scoliosis leads inevitably to disability and early death was built on studies that mixed late-onset idiopathic scoliosis with early-onset, congenital, and neuromuscular curves — conditions with fundamentally different cardiopulmonary trajectories. That conflation caused decades of over-alarming patients and families.
This paper reframes late-onset idiopathic scoliosis as primarily a problem of deformity and cosmesis, not organ failure. When a patient with a lumbar or moderate thoracic curve asks whether they will end up disabled or die early, the answer from 50 years of controlled data is no. Not from pulmonary or mortality standpoints.
When you see a thoracic curve exceeding 80° with significant apical rotation, that is the patient who needs respiratory monitoring. Not every scoliosis patient who walks through your clinic. Curve type and apex location are the triage filters.
The surgical threshold of 40°–50° Cobb angle exists to halt progression and address cosmesis in skeletally immature patients whose curves will continue growing at roughly 1° per year into adulthood. You are not primarily preventing death or respiratory failure for most patients. You are preventing deformity.
Weinstein later used this natural history dataset as the untreated benchmark in the BRAIST trial (NEJM 2013), making this study the epidemiological foundation for modern bracing evidence.
This prospective natural history study followed 117 untreated late-onset idiopathic scoliosis patients from the University of Iowa over 50 years. Patients were evaluated at mean age 66 and compared to 62 age-matched controls. The study answers: what actually happens to mortality, pain, pulmonary function, and daily function when late-onset idiopathic scoliosis goes untreated for five decades?
The dogma that untreated idiopathic scoliosis leads inevitably to disability and early death was built on studies that mixed late-onset idiopathic scoliosis with early-onset, congenital, and neuromuscular curves — conditions with fundamentally different cardiopulmonary trajectories. That conflation caused decades of over-alarming patients and families.
This paper reframes late-onset idiopathic scoliosis as primarily a problem of deformity and cosmesis, not organ failure. When a patient with a lumbar or moderate thoracic curve asks whether they will end up disabled or die early, the answer from 50 years of controlled data is no. Not from pulmonary or mortality standpoints.
When you see a thoracic curve exceeding 80° with significant apical rotation, that is the patient who needs respiratory monitoring. Not every scoliosis patient who walks through your clinic. Curve type and apex location are the triage filters.
The surgical threshold of 40°–50° Cobb angle exists to halt progression and address cosmesis in skeletally immature patients whose curves will continue growing at roughly 1° per year into adulthood. You are not primarily preventing death or respiratory failure for most patients. You are preventing deformity.
Weinstein later used this natural history dataset as the untreated benchmark in the BRAIST trial (NEJM 2013), making this study the epidemiological foundation for modern bracing evidence.